ELUT Q1 2024 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$48M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+4.7% YoY

Gross Profit

$3M42.5% margin

Operating Income

-$8M-126.7% margin

Net Income

-$18M-268.8% margin

EPS (Diluted)

$-0.75

QoQ Revenue Growth

+13.9%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$35M

Total Liabilities

$86M

Stockholders' Equity

-$50M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$6M	+4.7%
Gross Profit	$3M	$3M	-15.7%
Operating Income	-$8M	-$8M	-1.7%
Net Income	-$18M	-$8M	-125.7%

Revenue Segments

Women's Health

$4M82%

Cardiovascular

$770,00018%